First human trial of lassa fever pill shows promise in safety check
NCT ID NCT05735249
First seen May 03, 2026 · Last updated May 23, 2026 · Updated 3 times
Summary
This early-stage study tested a new oral drug called ARN-75039, being developed to treat Lassa fever, a serious viral illness. The trial involved 94 healthy adults to check the drug's safety and how the body processes it. Participants received either the drug or a placebo in single or multiple doses. The goal was to see if the drug is safe enough to move into future studies with infected patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Spaulding Clinical, LLC
West Bend, Wisconsin, 53095, United States
Conditions
Explore the condition pages connected to this study.